Sorafenib in lung cancer: clinical developments and future directions. [electronic resource]
Producer: 20080922Description: S124-7 p. digitalISSN:- 1556-1380
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Benzenesulfonates -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Female
- Follow-Up Studies
- Forecasting
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Neoplasm Staging
- Neovascularization, Pathologic -- prevention & control
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Pyridines -- administration & dosage
- Randomized Controlled Trials as Topic
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- Risk Assessment
- Sorafenib
- Survival Analysis
- Treatment Outcome
- Vascular Endothelial Growth Factors -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.